Harry Kleanthous
Corporate Officer/Principal en SK BIOSCIENCE CO.,LTD. .
Cargos activos de Harry Kleanthous
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SK BIOSCIENCE CO.,LTD. | Corporate Officer/Principal | 21/10/2022 | - |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Corporate Officer/Principal | - | - |
Historial de carrera de Harry Kleanthous
Formación de Harry Kleanthous.
| University of London | Doctorate Degree |
Estadísticas
Internacional
| Reino Unido | 3 |
| Corea del Sur | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SK BIOSCIENCE CO.,LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
- Bolsa de valores
- Insiders
- Harry Kleanthous
- Experiencia
